New York, NY, Feb. 26, 2019 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Bleeding Disorder Treatment Market by Type (Hemophilia A, Hemophilia B, Von Willebrand Disease, and Others) and by Drug Class (Plasma-Derived Coagulation Factor Concentrates, Recombinant Coagulation Factor Concentrates, Desmopressin, Antifibrinolytic, Fibrin Sealants, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025”. According to the report, the global bleeding disorder treatment market was valued at approximately USD 11.06 billion in 2018 and is expected to generate around USD 18.95 billion by 2025, at a CAGR of around 8% between 2019 and 2025.
Blood clotting is a mechanism that is activated when an injury results in bleeding inside or outside of the body. The clotting factors and certain plasma proteins are mainly responsible for the blood clotting mechanism. Blood disorders is a condition that involves malfunctioning of the clotting factors and plasma proteins, where blood clotting mechanism either occurs slowly or doesn’t occur at all. The growing awareness about the treatment of blood disorders, improvement in the technology for treating these disorders, and growing R&D activities for the development of recombinant factors are other factors projected to drive the global bleeding disorder treatment market in the future.
Browse through 37 Tables & 25 Figures spread over 110 Pages and in-depth TOC on “Global Bleeding Disorders Treatment Market Size, Share Analysis and Forecast, 2018–2025”.
Request Free Sample Report of Global Bleeding Disorder Treatment Market Report @ https://www.zionmarketresearch.com/sample/bleeding-disorders-treatment-market
The global bleeding disorder treatment market is divided on the basis of type, drug class, and region. By type, the market for bleeding disorder treatment is segmented into hemophilia B, hemophilia A, Von Willebrand disease, and others. The growing prevalence rate of hemophilia A is anticipated to fuel the hemophilia A segment in the global bleeding disorder treatment market. According to the U.S. Centers for Disease Control and Prevention, the prevalence of hemophilia A is four times more as compared to hemophilia B.
On the basis of drug class, the bleeding disorder treatment market is sectored into plasma-derived coagulation factor concentrates, desmopressin, fibrin sealants, antifibrinolytic, recombinant coagulation factor concentrates, and others. Recombinant coagulation factor concentrates held the maximum share of the blood disorder treatment market globally in 2018, due to the lesser infection risk is related to its use. The growing research and development activities for various recombinant factors by pharmaceutical and biotechnological companies to treat blood disorders are anticipated to further fuel the growth of this segment in the future.
Download Free Report PDF Brochure: https://www.zionmarketresearch.com/requestbrochure/bleeding-disorders-treatment-market
By region, North America is projected to dominate the global market for blood disorder treatment in the future. The increase in awareness and acceptance about prophylaxis treatment in the U.S. is likely to drive the North American bleeding disorder treatment market over the forecast time period. According to the National Hemophilia Foundation, about 20,000 individuals out of the total population suffer from hemophilia in the U.S. Approximately 80% of the total hemophilia population may further suffer from other blood-related diseases, such as AIDS. This, in turn, fuels the growth of the treatment for bleeding disorders in North America. Additionally, the increasing prevalence of Von Willebrand disease and the presence of the major companies in North America is anticipated to further fuel the bleeding disorder treatment market in the future.
The European bleeding disorder treatment market is anticipated to hold the second largest share of the global market in the years ahead, owing to the growing prevalence of various bleeding disorders, such as hemophilia, the presence of highly developed healthcare infrastructure, new initiatives introduced by the government, and the introduction of the technologically advanced products.
Browse the full “Bleeding Disorder Treatment Market by Type (Hemophilia A, Hemophilia B, Von Willebrand Disease, and Others) and by Drug Class (Plasma-Derived Coagulation Factor Concentrates, Recombinant Coagulation Factor Concentrates, Desmopressin, Antifibrinolytic, Fibrin Sealants, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025” Report at https://www.zionmarketresearch.com/report/bleeding-disorders-treatment-market
The Asia Pacific bleeding disorder treatment market is anticipated to show the highest growth rate over the estimated timeframe. According to the Hemophilia Federation of India, in 2011, about 14,000 hemophilia cases were registered. However, some hemophilia cases in India were not registered and remained under-diagnosed. The rising awareness regarding the treatment for hemophilia and other bleeding disorders and the introduction of technologically advanced products required for treatment are anticipated to fuel the growth of the region’s bleeding disorder treatment market in the future. Additionally, the increasing medical tourism due to the rising capital investments made by major companies and government in India, China, and Japan are likely to further propel the bleeding disorder treatment market. The rising expenditure related to healthcare is also anticipated to boost the region’s bleeding disorder treatment market in the future.
The Middle Eastern and African and Latin American regions are projected to exhibit steady growth during the forecast time period. The development of the healthcare infrastructure, rising awareness due to wide acceptance of e-commerce activities, and growing incidences of bleeding disorders and diseases are anticipated to fuel the growth of the bleeding disorder treatment market in these regions in the future.
Inquire more about this report before purchase @ https://www.zionmarketresearch.com/inquiry/bleeding-disorders-treatment-market
Some key players of the global bleeding disorder treatment market are Bayer AG, CSL Behring, Novo Nordisk, Pfizer Inc., Shire PLC, Grifols SA, Octapharma, Amgen Inc., Cangene Corporation, and Alnylam Pharmaceuticals.
Request customized copy of report @ https://www.zionmarketresearch.com/custom/2855
This report segments the global bleeding disorder treatment market as follows:
Global Bleeding Disorder Treatment Market: Type Analysis
- Hemophilia A
- Hemophilia B
- Von Willebrand Disease
- Others
Global Bleeding Disorder Treatment Market: Drug Class Analysis
- Plasma-Derived Coagulation Factor Concentrates
- Recombinant Coagulation Factor Concentrates
- Desmopressin
- Antifibrinolytic
- Fibrin Sealants
- Others
Global Bleeding Disorder Treatment Market: Regional Analysis
- North America
- The U.S.
- Europe
- UK
- France
- Germany
- Asia Pacific
- China
- Japan
- India
- Latin America
- Brazil
- The Middle East and Africa
Browse More Related Reports:
- Cannabidiol Products Market: https://www.zionmarketresearch.com/report/cannabidiol-products-market
- Cannabis Edibles Market: https://www.zionmarketresearch.com/report/cannabis-edibles-market
- Cannabis Beverages Market: https://www.zionmarketresearch.com/report/cannabis-beverages-market
- Healthcare Chatbots Market: https://www.zionmarketresearch.com/report/healthcare-chatbots-market
- mHealth Apps Market: https://www.zionmarketresearch.com/report/mhealth-apps-market
About Us:
Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Follow Us LinkedIn: https://www.linkedin.com/company/zion-market-research
Follow Us Twitter: https://twitter.com/zion_research
Blog: http://zmrindustryjournal.us | http://zmrresearchnews.us | http://zmrmarketjournal.com | https://zmrnewsjournal.us | http://zmrnewsmagazine.com | https://zmrnewsblog.com
Contact Us:
Joel John
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com
Blog: http://zmrblog.com